FSP Models Aren’t Just For Large Pharma Anymore
FSP partnerships don’t just offer benefits to large pharmaceutical companies, they can also support the needs of smaller companies as well.
Large pharmaceutical companies often favor adopting functional service provider (FSP) models over full-service outsourcing across their clinical and research and development operations. But must FSP models be the exclusive domain of the largest companies?
In this white paper, Syneos Health experts contend that FSP partnerships also offer benefits to smaller companies. This should come as good news to mid-sized sponsors hoping to level the playing field by taking advantage of development speed, efficiencies and higher-quality outcomes. Knowing when, how and where to begin is not intuitive and can best be decided with the help of experts who understand what solutions and resources are appropriate for a small to mid-sized company.
Related Content
Looking for exclusive insight?
